Hospital of the University of Münster, Department of Cardiology and Angiology, Germany.
Clin Cardiol. 2010 Dec;33(12):E51-9. doi: 10.1002/clc.20323. Epub 2010 Oct 26.
Contrast media-induced nephropathy (CIN) is associated with markedly increased morbidity and mortality. Although creatinine is at present routinely used to characterize renal function, many studies and guidelines recommend using the estimated glomerular filtration rate (eGFR) since it was found to be much more accurate.
To assess whether the eGFR or creatinine alone provided a better predictive value for long-term mortality after contrast media-associated renal impairment.
From a prospective trial with 412 patients undergoing heart catheterization, creatinine and eGFR before and after 24 h, 48-72 h, and 30 d after contrast-media exposure were assessed as well as long-term mortality.
Univariate Cox regression models identified increases in creatinine after 48 h (hazard rate ratio [HRR] 1.754, 95% confidence interval [CI] 1.134-2.712) and 30 d (HRR 3.157, 95% CI 1.968-5.064) as well as decreases in eGFR after 30 d (HRR 0.962, 95% CI 0.939-0.986) to be significant predictors of long-term mortality. However, by multivariable Cox regression, only increases in creatinine after 48 h (HRR 1.608, 95% CI 1.002-2.581) and after 30 d (HRR 2.685, 95% CI 1.598-4.511) turned out to be significant and independent predictors of mortality. With regard to a possibly critical threshold of creatinine increase, our data confirmed the historically grown increase in creatinine of 0.5 mg/dl or more during the first 48 h as being associated with increased mortality (p = 0.016, log rank test).
Serum creatinine, but not eGFR, was predictive for long-term mortality, with a threshold of 0.5 mg/dl or more indicating worse prognosis.
对比剂肾病(CIN)与发病率和死亡率的显著增加相关。虽然目前肌酐常规用于描述肾功能,但许多研究和指南建议使用估算肾小球滤过率(eGFR),因为它被发现更准确。
评估在对比剂相关肾损伤后,eGFR 或肌酐单独预测长期死亡率的能力。
对接受心导管检查的 412 例患者进行前瞻性试验,评估造影剂暴露后 24 小时、48-72 小时和 30 天的肌酐和 eGFR,并评估长期死亡率。
单因素 Cox 回归模型确定 48 小时后肌酐升高(危险比 [HRR] 1.754,95%置信区间 [CI] 1.134-2.712)和 30 天后肌酐升高(HRR 3.157,95% CI 1.968-5.064)以及 30 天后 eGFR 下降(HRR 0.962,95% CI 0.939-0.986)是长期死亡率的显著预测因子。然而,通过多变量 Cox 回归,只有 48 小时后肌酐升高(HRR 1.608,95% CI 1.002-2.581)和 30 天后肌酐升高(HRR 2.685,95% CI 1.598-4.511)被证明是死亡率的显著和独立预测因子。关于肌酐升高的可能临界阈值,我们的数据证实了历史上在最初 48 小时内肌酐增加 0.5mg/dl 或更多与死亡率增加相关(p=0.016,对数秩检验)。
血清肌酐而非 eGFR 可预测长期死亡率,阈值为 0.5mg/dl 或更高表明预后更差。